Publications by authors named "Monica Else"

Claim this Profile
T
Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials.
Louise Carr, Kevin Norris, Helen Parker, Anna Nilsson-Takeuchi, Dean Bryant, Monica Else

Br J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukemia variant and WHO classification correspondence Re: 5 edition WHO classification haematolymphoid tumors: lymphoid neoplasms.
Michael Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Monica Else

Leukemia· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a distributed international patient data registry for hairy cell leukemia.
Leslie A Andritsos, Mirela Anghelina, Jasmine Neal, James S Blachly, Puneet Mathur, Monica Else

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Monica Else

Blood Cancer J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia.
Alessandro Broccoli, Lisa Argnani, Matthew Cross, Agnieszka Janus, Elsa Maitre, Monica Else

Blood Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial.
Monica Else, Stuart J Blakemore, Jonathan C Strefford, Daniel Catovsky

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early clinical trials in chronic lymphocytic leukaemia in the UK.
Daniel Catovsky, Monica Else

Br J Haematol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial.
Stuart J Blakemore, Ruth Clifford, Helen Parker, Pavlos Antoniou, Ewa Stec-Dziedzic, Monica Else

Leukemia· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
Tomasz K Wojdacz, Harindra E Amarasinghe, Latha Kadalayil, Alice Beattie, Jade Forster, Monica Else

Blood Adv· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
Michael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, Versha Banerji, Jacqueline Barrientos, Monica Else

Blood· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.
David Oscier, Monica Else, Estella Matutes, Ricardo Morilla, Jonathan C Strefford

Br J Haematol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years.
Monica Else, Rachel Wade, David Oscier, Daniel Catovsky

Br J Haematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy.
Nadav Sarid, Humayun N Ahmad, Andrew Wotherspoon, Claire E Dearden, Monica Else

Br J Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
Monica Else, Claire E Dearden, Daniel Catovsky

Best Pract Res Clin Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent CDKN1B (p27) mutations in hairy cell leukemia.
Sascha Dietrich, Jennifer Hüllein, Stanley Chun-Wei Lee, Barbara Hutter, David Gonzalez, Monica Else

Blood· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of patients' sex in chronic lymphocytic leukemia.
Daniel Catovsky, Rachel Wade, Monica Else

Haematologica· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia.
Gillian G Johnson, Ke Lin, Trevor F Cox, Melanie Oates, David R Sibson, Monica Else

Blood· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.
David Gonzalez, Monica Else, Dorte Wren, Monica Usai, Anne Mette Buhl

Haematologica· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.
David G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, David Gonzalez de Castro, Belen Gomez, Monica Else

Blood· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
Monica Else, Ana Marín-Niebla, Fátima de la Cruz, Paul Batty, Eduardo Ríos

Br J Haematol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.
Sarah L Hockley, Monica Else, Alison Morilla, Andrew Wotherspoon, Claire Dearden

Br J Haematol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial.
Monica Else, Kim Cocks, Shirley Crofts, Rachel Wade, Sue M Richards

Leuk Lymphoma· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*.
Gail Jones, Nilima Parry-Jones, Bridget Wilkins, Monica Else, Daniel Catovsky

Br J Haematol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route.
Claire E Dearden, Amit Khot, Monica Else, Mike Hamblin, Effie Grand

Blood· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chlorambucil--still not bad: a reappraisal.
Daniel Catovsky, Monica Else, Sue Richards

Clin Lymphoma Myeloma Leuk· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis